AGTR1, angiotensin II receptor type 1, 185

N. diseases: 440; N. variants: 33
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 AlteredExpression disease BEFREE In transient transfection experiments, Angiotensin II type 1 receptor and Prostaglandin E receptor 4 promoters consistently gave higher expression in matched ductus arteriosus versus aorta cells from multiple patients. 27465141 2016
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 Biomarker disease BEFREE Our data describe the involvement of AT1R in PDA cell apoptotic machinery and provide the first evidences that losartan stimulates the proapoptotic signaling pathways regardless of the p53 mutation status. 20118823 2010
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 GeneticVariation disease BEFREE This prompted additional analysis with an additional set of 162 infants, focusing on the 7 markers with initial P values of <.01, and 1 genetic variant in the angiotensin II type I receptor previously shown to be related to patent ductus arteriosus. 19336370 2009
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 Biomarker disease CTD_human This prompted additional analysis with an additional set of 162 infants, focusing on the 7 markers with initial P values of <.01, and 1 genetic variant in the angiotensin II type I receptor previously shown to be related to patent ductus arteriosus. 19336370 2009
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 Biomarker disease BEFREE An AT1R antagonist significantly (p<0.05) inhibited the AngII-mediated induction of VEGF messenger RNA and protein in all PDA cell lines. 18026817 2008
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 Biomarker disease BEFREE We have investigated whether the presence of AT1R CC1166 influences the effect of prophylactic indomethacin treatment on the closure of DA until the fifth postnatal day in preterm infants. 12904590 2003
CUI: C0013274
Disease: Patent ductus arteriosus
Patent ductus arteriosus
0.350 Biomarker disease CTD_human We have investigated whether the presence of AT1R CC1166 influences the effect of prophylactic indomethacin treatment on the closure of DA until the fifth postnatal day in preterm infants. 12904590 2003